0001209191-17-003700.txt : 20170113 0001209191-17-003700.hdr.sgml : 20170113 20170113170115 ACCESSION NUMBER: 0001209191-17-003700 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20170112 FILED AS OF DATE: 20170113 DATE AS OF CHANGE: 20170113 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: MATEON THERAPEUTICS INC CENTRAL INDEX KEY: 0000908259 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 133679168 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 701 GATEWAY BLVD. STREET 2: SUITE 210 CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 BUSINESS PHONE: 650-635-7000 MAIL ADDRESS: STREET 1: 701 GATEWAY BLVD. STREET 2: SUITE 210 CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 FORMER COMPANY: FORMER CONFORMED NAME: OXIGENE INC DATE OF NAME CHANGE: 19930628 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: CHAPLIN DAVID CENTRAL INDEX KEY: 0001167232 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-21990 FILM NUMBER: 17528490 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2017-01-12 0 0000908259 MATEON THERAPEUTICS INC MATN 0001167232 CHAPLIN DAVID C/O MATEON THERAPEUTICS, INC. 701 GATEWAY BLVD, SUITE 210 SOUTH SAN FRANCISCO CA 94080 1 1 0 0 Chief Scientific Officer Employee Stock Option (Right to Buy) 0.375 2017-01-12 4 A 0 262500 0.375 A 2027-01-12 Common Stock 262500 262500 D Dr. Chaplin was awarded options to purchase shares of Mateon Therapeutics, Inc. common stock, $0.01 par value per share, pursuant to the Mateon Therapeutics, Inc. 2017 Equity Incentive Plan in connection with his service as Chief Scientific Officer. The Options will vest in forty-eight equal monthly installments beginning one month after the grant date. /s/ Megan N. Gates, attorney-in-fact 2017-01-13